Researchers will study a reduced chemotherapy regimen for patients with blood cancer who underwent a stem cell transplant. The first patient has been ...

Marlena Murphy thought her mental health was fine, until her emotions took over while opening up about her experience. Photo credit: Melle HoustonIn ...

There is a quote from William Shakespeare’s “Romeo and Juliet” that asks “What’s in a name?” and my thoughts are a great deal. Names are a part of our ...

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular ...

We’ve made huge progress on cancer in the last 50 years.  But not all of it has been felt equally. People’s experience of the healthcare system, and ...

This is a non-independent article produced as part of a commercial deal with Guardian Labs and originally published on the Guardian website. There are ...

A novel combination is being tested in patients with prostate cancer.The first patient has been dosed in a phase 1/2 trial evaluating a novel treatment ...

Obesity may lead to an increased risk of moderate to severe chronic graft-versus-host disease (GVHD) in patients with blood cancer who underwent allogeneic ...

Have you ever wondered how you would feel after time has passed by since your diagnosis with cancer? This is a question I ask myself sometimes, especially ...

More than half of patients responded to treatment with Jakafi (ruxolitinib) plus Rezurock (belumosudil) to treat graft-versus-host disease (GVHD), according ...

Patients with polycythemia vera who are treated with rusfertide may not have to get a blood draw as frequently, research found.The novel drug, rusfertide, ...

Nearly all patients responded to the CAR-T cell therapy, Carvykti (ciltacabtagene autoleucel; cilta-cel), in a recent trial evaluating the agent in patients ...